Education
About Us
Working with TipRanks
Follow Us
Marimed (TSE:MRMD)
:MRMD
Total Valuation
MariMed has a market cap or net worth of C$37.49M. The enterprise value is C$108.73M.
Market CapC$37.49M
Enterprise ValueC$108.73M
Share Statistics
MariMed has 389,229,830 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding389,229,830
Owned by Insiders10.21%
Owned by Institutions0.18%
Financial Efficiency
MariMed’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is 5.32%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)5.32%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee220.93K
Profits Per Employee-17.01K
Employee Count715
Asset Turnover0.76
Inventory Turnover2.84
Valuation Ratios
The current PE Ratio of MariMed is -3.58. MariMed’s PEG ratio is 0.08.
PE Ratio-3.58
PS Ratio0.00
PB Ratio1.90
Price to Fair Value0.71
Price to FCF87.16
Price to Operating Cash Flow-11.99
PEG Ratio0.08
Income Statement
In the last 12 months, MariMed had revenue of 157.96M and earned -12.16M in profits. Earnings per share was -0.03.
Revenue157.96M
Gross Profit62.87M
Operating Income2.91M
Pretax Income-3.97M
Net Income-12.16M
EBITDA13.83M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -2.33M and capital expenditures 2.66M, giving a free cash flow of 326.00K billion.
Operating Cash Flow-2.33M
Free Cash Flow326.00K
Free Cash Flow per Share<0.01
Dividends & Yields
MariMed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change-60.78%
50-Day Moving Average0.12
200-Day Moving Average0.17
Relative Strength Index (RSI)37.24
Average Volume (3m)23.37K
Important Dates
MariMed upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date―
Financial Position
MariMed as a current ratio of 1.10, with Debt / Equity ratio of 594.32%
Current Ratio1.10
Quick Ratio0.41
Debt to Market Cap1.81
Net Debt to EBITDA5.87
Interest Coverage Ratio0.42
Taxes
In the past 12 months, MariMed has paid 8.16M in taxes.
Income Tax8.16M
Effective Tax Rate-2.06
Enterprise Valuation
MariMed EV to EBITDA ratio is 9.02, with an EV/FCF ratio of -21.19.
EV to Sales0.79
EV to EBITDA9.02
EV to Free Cash Flow-21.19
EV to Operating Cash Flow18.38
Balance Sheet
MariMed has C$7.20M in cash and marketable securities with $87.51M in debt, giving a net cash position of C$80.31M billion.
Cash & Marketable SecuritiesC$7.20M
Total Debt$87.51M
Net CashC$80.31M
Net Cash Per ShareC$0.21
Tangible Book Value Per ShareC$0.07
Margins
Gross margin is 34.54%, with operating margin of 1.84%, and net profit margin of -7.70%.
Gross Margin34.54%
Operating Margin1.84%
Pretax Margin-2.51%
Net Profit Margin-7.70%
EBITDA Margin8.76%
EBIT Margin1.88%
Analyst Forecast
The average price target for MariMed is C$0.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$0.25
Price Target Upside147.68% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―